TrialBlood advances2020

Determining the recommended dose of pacritinib: results from the PAC203 dose-finding trial in advanced myelofibrosis.

Aaron T Gerds et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.